tiprankstipranks
Veracyte Shareholders Approve Directors and 2023 Plan Amendment
Company Announcements

Veracyte Shareholders Approve Directors and 2023 Plan Amendment

Don't Miss Our Christmas Offers:

Veracyte (VCYT) just unveiled an update.

At the Company’s Annual Meeting, stockholders elected two directors to serve until the 2025 annual meeting, with a clear majority voting in favor. Additionally, Ernst & Young LLP was ratified as the independent registered public accounting firm for 2024. The compensation of the Company’s named executive officers received a non-binding advisory approval. Furthermore, the 2023 Plan Amendment was approved by shareholders, signaling confidence in the company’s strategic direction and governance.

For detailed information about VCYT stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyVeracyte downgraded to Neutral from Buy at Goldman Sachs
TheFlyVeracyte price target raised to $28 from $26 at Morgan Stanley
TheFlyMorgan Stanley, Comerica upgraded: Wall Street’s top analyst calls
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App